ContractCooperative Agreement • February 14th, 2025
Contract Type FiledFebruary 14th, 2025Cooperative Agreement IP-22-004: US Platform to Measure Effectiveness of Seasonal Influenza, COVID-19 and other Respiratory Virus Vaccines for the Prevention of Acute Illness in Ambulatory Settings